Shared on04 Aug 25Fair value Increased 5.72%
Jubilant Ingrevia's consensus analyst price target has increased to ₹967.67, primarily reflecting improved net profit margins despite a slight moderation in expected revenue growth. What's in the News Board meeting scheduled to consider unaudited standalone and consolidated financial results for the quarter ended June 30, 2025.
Shared on23 Apr 25
AnalystConsensusTarget has decreased profit margin from 9.2% to 7.6% and increased future PE multiple from 32.7x to 39.4x.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 2.38%
AnalystConsensusTarget has increased profit margin from 7.6% to 9.2% and decreased future PE multiple from 40.5x to 32.7x.
Shared on02 Apr 25Fair value Decreased 0.46%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on13 Mar 25Fair value Decreased 0.0052%
AnalystConsensusTarget has increased revenue growth from 13.9% to 17.8% and decreased profit margin from 8.7% to 7.6%.